$Moleculin Biotech(MBRX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001659617-20-000006 Act: 34 Size: 8 MB 网页链接
$Moleculin Biotech(MBRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001535610-20-000019 Act: 34 Size: 13 KB 网页链接
$Moleculin Biotech(MBRX)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001659617-19-000202 Act: 33 Size: 1 MB 网页链接
$Moleculin Biotech(MBRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001659617-19-000193 Act: 34 Size: 222 KB 网页链接
$Moleculin Biotech(MBRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001659617-19-000186 Act: 34 Size: 239 KB 网页链接
$Moleculin Biotech(MBRX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001659617-19-000177 Act: 34 Size: 224 KB 网页链接
$Moleculin Biotech(MBRX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001659617-19-000173 Act: 34 Size: 221 KB 网页链接
$Moleculin Biotech(MBRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001659617-19-000169 Act: 34 Size: 6 MB 网页链接
$Moleculin Biotech(MBRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001659617-19-000170 Act: 34 Size: 431 KB 网页链接
$Moleculin Biotech(MBRX)$ 8-K - Current report Filed: 2019-10-29 AccNo: 0001659617-19-000159 Size: 224 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接